Haegarda
Generic name: C1 Esterase Inhibitor Subcutaneous (human)
Drug class:
Hereditary angioedema agents
Usage of Haegarda
Haegarda is a man-made form of a protein in blood that helps control swelling in the body. People with a condition called Hereditary Angioedema (HAE) do not have enough of this protein. Hereditary Angioedema can cause attacks of swelling and symptoms such as stomach problems or trouble breathing.
Haegarda is an injectable medicine used to prevent swelling and/or painful attacks in patients 6 years of age and older with Hereditary Angioedema.
Haegarda should not be used to treat an acute HAE attack. In case of an acute HAE attack, initiate individualized treatment as discussed with your health care professional.
Haegarda side effects
Get emergency medical help if you have signs of an allergic Reaction to Haegarda: hives; chest tightness, fast heartbeats, feeling light-headed; wheezing or difficult breathing, blue lips or gums; or swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Haegarda side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Haegarda
You should not use Haegarda if have ever HAD a life-threatening allergic reaction to c1 esterase inhibitor.
To make sure Haegarda is safe for you, tell your doctor if you have:
Tell your doctor if you are pregnant or breast-feeding.
Haegarda is made from donated human plasma and may contain viruses or other infectious agents. Donated plasma is tested and treated to reduce the risk of contamination, but there is still a small possibility it could transmit disease. Ask your doctor about any possible risk.
Relate drugs
- Complement C1 esterase inhibitor
- Conestat alfa
- C1 esterase inhibitor recombinant
- C1 esterase inhibitor, human
- Berinert
- Berotralstat
- Cinryze
- Ecallantide
- Firazyr
- Haegarda
- Icatibant
- kalbitor
- Lanadelumab
- Lanadelumab-flyo
- Orladeyo
- Ruconest
- Takhzyro
How to use Haegarda
Usual Adult Dose for Hereditary Angioedema:
Haegarda is intended for self-administration after reconstitution at a dose of 60 International Units (IU) per kg body weight by suBCUTAneous (S.C.) injection twice weekly (every 3 or 4 days). The patient or caregiver should be trained on how to administer the subcutaneous injection.
Use: routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks
Usual Pediatric Dose for Hereditary Angioedema:
Haegarda is intended for self-administration after reconstitution at a dose of 60 International Units (IU) per kg body weight by subcutaneous (S.C.) injection twice weekly (every 3 or 4 days). The patient or caregiver should be trained on how to administer the subcutaneous injection.
Use: routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older
Warnings
You should not use Haegarda if you have experienced life-threatening immediate hypersensitivity reactions (allergic reactions), including anaphylaxis, to the product.
What other drugs will affect Haegarda
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs interact with c1 esterase inhibitor, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions